SECTORS

DAIICHI SANKYO

Stock Exchange:
TOKYO
Sector:
Biotechnology
Sub-sector:
Pharmaceuticals
Turnover last year:
1.601.688 M¥ 2023
Profits last year:
201.016 M¥ 2023

Activity: Drug development.

DAIICHI SANKYO is a global biotechnology company. To highlight: cancer, cardiac dysfunctions and rare diseases.

OPEN GRAPHIC

https://www.daiichisankyo.com/